Lilly will use Rznomics’ proprietary ribozyme technology to develop RNA editing therapies for congenital hearing loss.

BACKGROUND: Exercise improves functional outcomes in patients with diabetic cardiomyopathy (DiaCM). The molecular mechanism ...

It’s been 11 years that I’ve been watching the enemy killing people. Nothing can surprise me any more — Ukrinform.